Legal & Regulatory Compliance

Last updated: April 2026

Overview

The legal status of research peptides varies by country and by individual compound. In most jurisdictions, peptides that have not received regulatory approval as medicines may be legally purchased and possessed for legitimate scientific and laboratory research purposes, provided they are not marketed for human consumption. This page provides a general overview of the regulatory landscape in each country we ship to. This is not legal advice. Laws change frequently, and we strongly recommend consulting local counsel or your country's regulatory authority before placing an order.

United States

Regulatory body: Food and Drug Administration (FDA)

Key legislation: Federal Food, Drug, and Cosmetic Act (21 USC); 21 CFR Parts 210–211

In the United States, research peptides sold as "for research use only" and "not for human consumption" occupy a well-established legal category. They are not classified as controlled substances under the Controlled Substances Act and are not scheduled by the DEA. The FDA regulates peptides as drugs only when they are marketed for therapeutic use in humans. Research-grade compounds sold without therapeutic claims fall outside FDA drug enforcement, though they remain subject to general consumer safety and honest labeling requirements. Purchasing research peptides for laboratory use is legal throughout the United States.

In February 2026, HHS announced that approximately 14 of 19 peptides on the FDA's Category 2 restricted compounding list would be reclassified to Category 1, restoring access through licensed compounding pharmacies. This reclassification applies to compounded medicines prescribed by physicians and is separate from the research chemical market.

Canada

Regulatory body: Health Canada

Key legislation: Food and Drugs Act (R.S.C., 1985, c. F-27); Natural Health Products Regulations

Health Canada regulates peptides intended for human use under the Food and Drugs Act. Products marketed for therapeutic purposes require a Drug Identification Number (DIN) or authorization as a clinical trial material. Research peptides that are clearly labeled for scientific use and are not marketed for human consumption can generally be imported for legitimate laboratory research. Buyers should ensure shipments are properly declared and labeled. Some peptides are classified as Schedule F (prescription-only) when intended for therapeutic use, but this classification does not apply to research chemicals purchased for laboratory purposes.

United Kingdom

Regulatory body: Medicines and Healthcare products Regulatory Agency (MHRA)

Key legislation: Human Medicines Regulations 2012; Misuse of Drugs Act 1971

Most research peptides (including BPC-157, GHK-Cu, and similar compounds) are not scheduled under the Misuse of Drugs Act 1971 in the United Kingdom, and possession for research purposes is not a criminal offense. The MHRA regulates substances as medicinal products when they are presented or intended for use in treating or preventing disease in humans. Research peptides sold and purchased strictly for scientific study, and clearly labeled as not for human consumption, generally fall outside MHRA jurisdiction. UK Border Force primarily targets controlled substances and unlicensed medicines at customs; properly labeled research compounds typically clear without issue. Sellers must not market peptides using language that implies therapeutic use for humans.

Germany

Regulatory body: Federal Institute for Drugs and Medical Devices (BfArM)

Key legislation: Arzneimittelgesetz (German Medicines Act, AMG)

Germany maintains strict pharmaceutical regulation through the AMG. Substances intended for use in or on humans to cure, alleviate, or prevent disease are classified as medicinal products and require BfArM authorization. Research chemicals sold for laboratory use and clearly labeled as not for human consumption are generally not classified as medicinal products under the AMG. However, enforcement can vary, and German customs may inspect imported research chemicals. Buyers should ensure all shipments include clear research-use labeling and documentation of the intended scientific purpose.

Netherlands

Regulatory body: Medicines Evaluation Board (CBG-MEB)

Key legislation: Geneesmiddelenwet (Dutch Medicines Act)

The Netherlands is generally one of the more permissive European countries for research chemicals. The Dutch Medicines Act regulates substances as medicines when intended for therapeutic use. Research peptides sold exclusively for scientific purposes, properly labeled, and not marketed with health claims are typically not classified as medicines under Dutch law. The Netherlands has a well-established research chemical market, and imports for legitimate laboratory use generally proceed through customs without issue. As with all EU countries, sellers may not make therapeutic claims about unregistered products.

France

Regulatory body: National Agency for the Safety of Medicines and Health Products (ANSM)

Key legislation: Code de la santé publique (Public Health Code)

France regulates medicinal products through the ANSM and the Public Health Code. Research peptides fall into a gray area: they are not explicitly illegal to purchase for scientific research purposes, but the ANSM can classify any substance with pharmacological activity as a medicinal product if it is presented for therapeutic use. Buyers in France should ensure products are ordered strictly for laboratory research, that no therapeutic claims are made, and that shipments are properly declared at customs. French customs may inspect international shipments containing research chemicals.

Ireland

Regulatory body: Health Products Regulatory Authority (HPRA)

Key legislation: Irish Medicines Board Acts 1995–2006; Medicinal Products Regulations

Ireland's regulatory framework is similar to the UK's. Research peptides that are not scheduled as controlled substances and are not marketed for human use can generally be purchased and imported for laboratory research. The HPRA regulates medicinal products — substances that are presented as having properties for treating or preventing disease — and research chemicals sold strictly for scientific use typically fall outside this scope. Imports should be properly labeled and declared.

Your Responsibility

By purchasing from Veritas Compounds, you acknowledge and agree that:

• You are solely responsible for ensuring your purchase complies with all applicable laws in your jurisdiction.
• You will use all products exclusively for legitimate laboratory research purposes.
• You will not administer any product to humans or animals.
• You understand that regulatory landscapes change and that it is your obligation to verify current laws before ordering.
• Veritas Compounds makes no representations or warranties regarding the legality of these products in your specific jurisdiction.
• Veritas Compounds is not liable for any legal consequences arising from your purchase, importation, or use of these products.

Customs & Importation

All orders ship internationally. Packages are discreetly packaged and contain no therapeutic claims or labeling that could be interpreted as marketing a medicinal product. If your shipment is intercepted or held by customs authorities, please contact us with your order number and any customs documentation you received. We offer a one-time reshipment for packages seized by customs. See our Terms & Conditions and Shipping Policy for full details.

Questions

If you have questions about the regulatory status of a specific compound in your country, please contact us before placing your order. We are happy to help you determine whether we can ship to your location.